Abstract: A multilayered composite or coated substrate, comprising compounds of which at least 40% by weight are composed of alpha-amino acids linked via peptide bonds as adhesion promoters between at least two adjacent layers of the composite or between the coating and the substrate.

Abstract: Expandable or expanded, thermoplastic polymer particles with a coating comprising hydrophobin, in particular proteins of the general structural formula (I) Xn-C1-X1-50-C2-X0-5-C3-X1-100-C4-X1-100-C5-X1-50-C6-X0-5-C7-X1-50-C8-Xm??(I) where X is any of the 20 naturally occurring amino acids, n and m are numbers between 0 and 500, C is cysteine, and their use as antistatics.

Abstract: Polypeptides of the general structural formula (I) Xn—C1—X1-50—C2—X0-5—C3—Xp—C4—X1-100—C5—X1-50—C6—X0-5—C7—X1-50—C8—Xm??(I), production and use thereof.

Abstract: Cosmetic composition for the treatment of keratin-containing materials, mucosa and teeth, comprising at least one hydrophobin polypeptide sequence (i) (I) Xn-C1-X1-50-C2-X0-5-C3-Xp-C4-X1-100-C5-X1-50-C6- X0-5-C7-X1-50-C8-Xm

Abstract: Fibrous substrates selected from textile substrates and leather are coated using at least one hydrophobin.

Abstract: The use of interface-active non-enzymatic proteins for textile washing. Washing compositions for textile washing which comprise interface-active non-enzymatic proteins, and processes for washing using such proteins.

Abstract: Polypeptides of the general structural formula (I) Xn—C1—X1-50—C2—X0-5—C3—X1-100—C4—X1-100—C5—X1-50—C6—C0-5—C7—X1-50—C8—Xm??(I) production and use thereof.

Abstract: Emulsions of hydrophobic monomers in water comprising inorganic particles as Pickering emulsifiers, and hydrophobin; and also the preparation and use of the emulsions are described.

Abstract: A method for coating surfaces with hydrophobin fusions at a pH of ?4, and a surface having a coating which comprises at least one hydrophobin fusion.

Abstract: The invention relates to the use of cyclic compounds as ligands of integrin receptors, in particular as ligands of the ?V?3 integrin receptor, the novel compounds themselves, their use, and pharmaceutical preparations comprising these compounds.

Abstract: The invention relates to novel keratin-binding protein active substances, and also to the production and use thereof. Particularly suitable keratin-binding polypeptides are sequences which are contained in human desmoplakin or are derived therefrom by altering the human desmoplakin polypeptide sequences such as amino acid insertions, substitutions or deletions. The polypeptide sequences of the human desmoplakin is represented in SEQ ID NO: 1. A suitable keratin-binding domain (domain B) is the polypeptide sequence SEQ ID NO: 1, position 2193 2481, in addition to functional equivalents thereof. An additional keratin-binding domain (domain C) is the polypeptide sequence SEQ ID NO: 1, position 2606 2871 and the functional equivalents thereof.

Abstract: The invention relates to a method for removing horn substances from animal skin. The method is characterized in that animal skins are treated in an aqueous bath containing between 0.05 and 5 wt. %, in relation to the weight of the salt, of at least one compound of general formula I or the corresponding alkali metallic salts or alkaline-earth metallic salts thereof or ammonium or phosphonium salts.

Abstract: Horny substances are removed from animal hides by a process wherein animal hides are treated in a liquor comprising from 0.05 to 5% by weight, based on the salted weight, of one or more compounds of the formula I or the corresponding alkali metal or alkaline earth metal or ammonium or phosphonium salts thereof, the variables being defined as follows: R1 is selected from hydrogen and C1-C12-alkyl, unsubstituted or substituted by one or more S—H or O—H groups; X1 to X4 are identical or different and are selected from hydrogen, C1-C4-alkyl, O—H, S—H and N—HR2, R2 is hydrogen or C1-C12-alkyl or a C1-C4-alkyl-C?O group, at least one of the radicals X1 to X4 being S—H, and, if R1 contains neither O—H nor S—H, at least one further radical from among X1 to X4 is selected from S—H, OH and NH—R2, and furthermore with at least one compound which catalyzes the hydrolysis of peptide bonds.

Abstract: The invention relates to novel compounds which bind to integrin receptors, to their preparation, to their use as integrin receptor ligands and for treating diseases, to pharmaceutical preparations comprising these compounds, and to pharmaceutical preparations comprising at least one other active compound.

Abstract: The invention relates to novel compounds which bind to integrin receptors, and to the preparation thereof and the use thereof as drugs.

Abstract: The invention relates to compounds of the formula I and their tautomeric forms, possible enantiomeric and diastereomeric forms and their prodrugs, and to their preparation and use, where A, B, R1 and X1 have the meanings given in the description.

Abstract: The invention relates to a method for removing horn substances from animal skin. Said method is characterised in that animal skins are treated in an aqueous bath containing between 0.05 and 5 wt. %—in relation to the weight of the salt—of at least one compound of general formula I or the corresponding alkali metallic salts or alkaline-earth metallic salts thereof or ammonium or phosphonium salts, the variables having the following definitions: R1 is selected from hydrogen or C1-C12 alkyl, unsubstituted or substituted by at least one S—H group or one O—H group; X1 to X4 are the same or different and selected from hydrogen, C1-C4 alkyl, O—H, S—H or N—HR2; and R2 represents hydrogen or C1-C12 alkyl or a C1-C4-alkyl-C?O group, at least one X1 to X4 representing S—H. If R1 contains neither O—H nor S—H, at least one other X1 to X4 is selected from S—H, OH or NH—R2. Said aqueous bath also comprises at least one compound which catalyses the hydrolysis of peptide compounds.

Abstract: The invention relates to novel substituted pyrimidone derivatives which bind to integrin receptors, to their preparation and to their use.

Abstract: The disclosure is directed to compounds of the formula (I) 1

Abstract: The invention relates to compounds of the formula I 1